SmallCap
CompaniesMapStatistics

프리시젼바이오(주)

Listed
Venture Certified
Data Quality: 95/10

Basic Information


Listed

Stock Code: 335810

Company Name프리시젼바이오(주)
English NamePrecision Biosensor Inc.
Business Reg. No.3148608943
CEO김한신
Address대전시 유성구 테크노2로 306
Industry그 외 기타 의료용품 및 의약 관련제품 제조업
Industry Code27199
Established2009-09-28
Phone042-867-6300
Websiteprecision-bio.com/
Regular Employees98persons
Corp. Reg. No.1601110265995

Investment Metrics


Market Cap
-
Op. Margin
-21%
ROE
-15.9%
Debt Ratio
83.72%

Certification Status


Venture Certified

Cert. History
기술평가보증기업(기금)2012-04-25 ~ 2014-04-24201201037312012-04-25
벤처투자유형2016-09-01 ~ 2018-08-31201603004172012-04-25
벤처투자유형2018-09-01 ~ 2020-08-31201803005722012-04-25
벤처투자유형2020-09-01 ~ 2022-08-31202003009892012-04-25
벤처투자유형2022-09-01 ~ 2025-08-31202208110100052012-04-25
벤처투자유형2025-09-01 ~ 2028-08-31202507290100312012-04-25

Financial Statements


3-Year Financial Data

Revenue CAGR +2.4%

Item202420232022
Revenue

157B

173B

149B

Operating Profit

-33B

-25B

-39B

Net Profit

-47B

-29B

-62B

Total Assets

543B

623B

561B

Total Liabilities

248B

288B

235B

Total Equity

296B

335B

326B

Risk Indicators


2 Risk Indicators

Comparison Metrics


vs. 3-Year Avg.
Based on 2024
Revenue
157B

2.7%

vs. 3-Year Avg.: 161B
Operating Profit
-33B

2.9%

vs. 3-Year Avg.: -32B
Op. Margin
-21.0%

3.6%

vs. 3-Year Avg.: -20.3%
Debt Ratio
83.7%

5.9%

vs. 3-Year Avg.: 79.1%
ROE
-15.9%

15.0%

vs. 3-Year Avg.: -13.9%

Officers / Major Shareholders


Only CEO info available (unlisted company)
NamePositionRole
김한신대표이사대표

Employment Status


NPS Subscribers

98persons

CEO김한신
Est. Avg. Annual Salary

4,94110K

(41210K/mo)
Based on NPS rate 9.5%
Hired (12 mo)

+0persons

Left (12 mo)

-1persons

Net Change (12 mo)

-1persons

NPS Join Date

2009-09-28

Monthly Employee Trend
Hired
Left

Patent Status

Updated: 2026-02-25

No Data Contact

No patents found or data not yet available.

Procurement Record

Updated: 2026-02-25

No Data Contact

No procurement record or data not yet available

Support Programs


No Data Contact

No matching support programs for this industry

Tax / Business Status

Updated: 2026-02-25

Business Status: active
Tax Type부가가치세 일반과세자

SME Status


Venture
Status

Cert. flags confirmed (details update after further collection)

Other Public Data


2 Additional Data Sources

{
  "address": "대전광역시 유성구 테크노2로",
  "brno": "314860****",
  "cappedWarning": false,
  "companyName": "프리시젼바이오주식회사",
  "estimatedAvgAnnualSalary": 49409964,
  "estimatedAvgMonthlySalary": 4117497,
  "fetchedAt": "2026-03-05T21:00:27.020Z",
  "industryCode": "331201",
  "industryName": "물질 검사, 측정 및 분석 기구 제조업",
  "joinDate": "20090928",
  "last12MonthsHired": 0,
  "last12MonthsLeft": 1,
  "last12MonthsNetChange": -1,
  "leaveDate": null,
  "monthlyPensionAmount": 38333900,
  "monthlyTrend": [
    {
      "lostSubscribers": 1,
      "newSubscribers": 0,
      "yearMonth": null
    }
  ],
  "npsRateUsed": 0.095,
  "npsUpperCap": 6370000,
  "seq": "6709888",
  "status": "1",
  "styleCode": "1",
  "subscriberCount": 98,
  "turnoverMonths": 1
}

{
  "address": "대전광역시 유성구",
  "ceo_name": "김한신",
  "certificate": [
    {
      "cert_number": "20120103731",
      "changes": "",
      "disclosure_date": "2012-04-25",
      "first_cert_date": "2012-04-25",
      "no": "1",
      "type": "기술평가보증기업(기금)",
      "valid_period": "2012-04-25 ~ 2014-04-24"
    },
    {
      "cert_number": "20160300417",
      "changes": "",
      "disclosure_date": "2016-09-01",
      "first_cert_date": "2012-04-25",
      "no": "2",
      "type": "벤처투자유형",
      "valid_period": "2016-09-01 ~ 2018-08-31"
    },
    {
      "cert_number": "20180300572",
      "changes": "",
      "disclosure_date": "2018-08-23",
      "first_cert_date": "2012-04-25",
      "no": "3",
      "type": "벤처투자유형",
      "valid_period": "2018-09-01 ~ 2020-08-31"
    },
    {
      "cert_number": "20200300989",
      "changes": "",
      "disclosure_date": "2020-08-27",
      "first_cert_date": "2012-04-25",
      "no": "4",
      "type": "벤처투자유형",
      "valid_period": "2020-09-01 ~ 2022-08-31"
    },
    {
      "cert_number": "20220811010005",
      "changes": "",
      "disclosure_date": "2022-08-11",
      "first_cert_date": "2012-04-25",
      "no": "5",
      "type": "벤처투자유형",
      "valid_period": "2022-09-01 ~ 2025-08-31"
    },
    {
      "cert_number": "20250729010031",
      "changes": "",
      "disclosure_date": "2025-07-29",
      "first_cert_date": "2012-04-25",
      "no": "6",
      "type": "벤처투자유형",
      "valid_period": "2025-09-01 ~ 2028-08-31"
    }
  ],
  "company_name": "프리시젼바이오(주)",
  "financials": {
    "2022": {
      "capital_stock": 5795663000,
      "cost_of_sales": 10622151000,
      "current_assets": 18464937000,
      "current_liabilities": 19399493000,
      "gross_profit": 4292310000,
      "net_income": -6202852000,
      "net_income_bs": -6208326000,
      "non_current_assets": 37648382000,
      "non_current_liabilities": 4149287000,
      "non_operating_expenses": 3183902000,
      "non_operating_income": 875943000,
      "operating_profit": -3894893000,
      "revenue": 14914461000,
      "sga_expenses": 8187203000,
      "total_assets": 56113319000,
      "total_equity": 32564538000,
      "total_liabilities": 23548781000
    },
    "2023": {
      "capital_stock": 5807263000,
      "cost_of_sales": 10551412000,
      "current_assets": 14324603000,
      "current_liabilities": 12658902000,
      "gross_profit": 6725847000,
      "net_income": -2910806000,
      "net_income_bs": -2119044000,
      "non_current_assets": 47945584000,
      "non_current_liabilities": 16103733000,
      "non_operating_expenses": 2099277000,
      "non_operating_income": 1684966000,
      "operating_profit": -2496495000,
      "revenue": 17277259000,
      "sga_expenses": 9222342000,
      "total_assets": 62270187000,
      "total_equity": 33507551000,
      "total_liabilities": 28762636000
    },
    "2024": {
      "capital_stock": 5807263000,
      "cost_of_sales": 10096123000,
      "current_assets": 13317088000,
      "current_liabilities": 18594643000,
      "gross_profit": 5558028000,
      "net_income": -4717947000,
      "net_income_bs": -4548793000,
      "non_current_assets": 41026609000,
      "non_current_liabilities": 6169046000,
      "non_operating_expenses": 3125993000,
      "non_operating_income": 1695897000,
      "operating_profit": -3287851000,
      "revenue": 15654152000,
      "sga_expenses": 8845879000,
      "total_assets": 54343697000,
      "total_equity": 29580008000,
      "total_liabilities": 24763689000
    }
  },
  "industry": "그 외 기타 의료용품 및 의약 관련제품 제조업",
  "investment": [
    {
      "amount": "7,999,917,000",
      "changes": "7,999,917,000",
      "date": "2019-08-22"
    },
    {
      "amount": "1,336,000,000",
      "changes": "1,336,000,000",
      "date": "2019-08-22"
    },
    {
      "amount": "445,000,000",
      "changes": "445,000,000",
      "date": "2019-08-22"
    },
    {
      "amount": "2,000,000,000",
      "changes": "2,000,000,000",
      "date": "2019-08-22"
    },
    {
      "amount": "1,999,998,000",
      "changes": "1,999,998,000",
      "date": "2019-08-22"
    }
  ],
  "phone": "042-867-****",
  "source": "pg_migration"
}

Data Sources


Data Quality: 95/10 | Primary Source: DART | Section Coverage: 8/8

Data Sources by Section
SectionSource:Status
Basic InfoDART
Collected
Financial StatementsVenture System
Collected
Investment MetricsVenture System
Collected
OfficersDART
Collected
EmploymentPublic Data
Collected
CertificationsPublic Data
Collected
PatentsKIPRIS
Collected
ProcurementG2B Procurement
Collected
Collected API Sources
APICollectedStatus
nps2026-03-05
Collected
Venture System Detail2026-03-05
Collected
DART Financial2026-02-26
Collected
G2B Procurement2026-02-25
Collected
Employment Insurance2026-02-25
Collected
KIPRIS Patents2026-02-25
Collected
HomeTax Business2026-02-25
Collected
Cert. Info2026-02-25
Collected